In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thoratec Takes Over REVIVE-IT LVAD Trial From HeartWare

This article was originally published in The Gray Sheet

Executive Summary

The pilot trial, cosponsored by NIH, will give ventricular assist devices a chance to prove their worth in heart failure patients not yet in the final stage of their illness.

You may also be interested in...



Study In Circulation Questions Cost Effectiveness Of VADs

A recent analysis of the cost effectiveness of ventricular assist devices used as destination therapy for heart failure suggests room for improvement.

Destination Therapy HeartMate II Implants Drives Thoratec’s Fast Growth

“Looking forward, we anticipate that the DT indication will continue to drive growth across the spectrum of centers, but with an increasingly important contribution from smaller transplant and open heart centers,” CEO Gerhard Burbach said.

FDA Sticks Newly Approved HeartWare VAD With Unexpected Labeling Requirement

HeartWare International Inc.’s HeartWare Ventricular Assist System has finally gained PMA approval, but FDA labeling requirements have sparked questions from analysts.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT032062

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel